| scholarly article | Q13442814 |
| P50 | author | Nadezda Apostolova | Q43661087 |
| P2093 | author name string | J V Esplugues | |
| A Alvarez | |||
| A Blas-Garcia | |||
| A Moran | |||
| L J Gomez-Sucerquia | |||
| P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes | Q27487541 | ||
| Cell death: critical control points | Q28240722 | ||
| Caspases 3 and 7: key mediators of mitochondrial events of apoptosis | Q28588439 | ||
| Free radicals, metals and antioxidants in oxidative stress-induced cancer | Q29547711 | ||
| Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 | ||
| Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients | Q31977562 | ||
| Growing tissue-like constructs with Hep3B/HepG2 liver cells on PHBV microspheres of different sizes | Q33260035 | ||
| Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. | Q34166941 | ||
| Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring | Q34464997 | ||
| Selective fluorescent imaging of superoxide in vivo using ethidium-based probes | Q35062293 | ||
| Toxicity of non-nucleoside analogue reverse transcriptase inhibitors | Q35151048 | ||
| Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism | Q35827416 | ||
| Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. | Q36032328 | ||
| Hepatotoxicity of antiretroviral drugs | Q36321070 | ||
| Central role of mitochondria in metabolic regulation of liver pathophysiology | Q36849033 | ||
| Cellular and molecular mechanisms of liver injury | Q36908855 | ||
| Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus | Q37215415 | ||
| Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel | Q37234205 | ||
| Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies | Q37244314 | ||
| Caspases in apoptosis and beyond | Q37302731 | ||
| Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor | Q39652630 | ||
| Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis | Q39867349 | ||
| Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. | Q40160898 | ||
| Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. | Q40395729 | ||
| Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. | Q40531832 | ||
| Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors | Q40693184 | ||
| Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse | Q40763086 | ||
| Flow cytometric measurement of mitochondrial mass and function: a novel method for assessing chemoresistance | Q41038244 | ||
| The specificity of neuroprotection by antioxidants | Q42647233 | ||
| Hepatotoxicity in patients prescribed efavirenz or nevirapine. | Q42980795 | ||
| Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells | Q43011656 | ||
| Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men. | Q43766805 | ||
| Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections | Q43851688 | ||
| Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team | Q44088437 | ||
| Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens | Q44309075 | ||
| A paediatric case of acute liver failure associated with efavirenz-based highly active antiretroviral therapy and effective use of raltegravir in combination antiretroviral treatment after liver transplantation | Q44556634 | ||
| An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapine | Q45239039 | ||
| Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team | Q45745660 | ||
| Are adverse events of nevirapine and efavirenz related to plasma concentrations? | Q46614058 | ||
| Oxidative stress-induced apoptosis prevented by Trolox | Q72150904 | ||
| Human hepatocyte culture | Q83830231 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | efavirenz | Q422645 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 2069-2084 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells | |
| P478 | volume | 160 |
| Q94601929 | Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice |
| Q38954255 | Antileishmanial activity of antiretroviral drugs combined with miltefosine. |
| Q33784656 | Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition |
| Q57299773 | Apoptosis inducing factor deficiency causes retinal photoreceptor degeneration. The protective role of the redox compound methylene blue |
| Q35007676 | Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicity |
| Q47141835 | Autophagy in drug-induced liver toxicity |
| Q37926590 | Central role of mitochondria in drug-induced liver injury |
| Q37460217 | Cited2 is required for the maintenance of glycolytic metabolism in adult hematopoietic stem cells |
| Q90253728 | Combination of Tenofovir and Emtricitabine with Efavirenz Does Not Moderate Inhibitory Effect of Efavirenz on Mitochondrial Function and Cholesterol Biosynthesis in Human T Lymphoblastoid Cell Line |
| Q43558721 | Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy |
| Q49726714 | Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation. |
| Q35076879 | Cytotoxicity of lidocaine to human corneal endothelial cells in vitro |
| Q36442232 | Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis |
| Q37139458 | EFV/FTC/TDF-associated hepatotoxicity: a case report and review |
| Q28548473 | Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells |
| Q28085028 | Efavirenz and the CNS: what we already know and questions that need to be answered |
| Q40386326 | Effect of the Anti-retroviral Drugs Efavirenz, Tenofovir and Emtricitabine on Endothelial Cell Function: Role of PARP. |
| Q92887670 | Effects of quercetin on bisphenol A-induced mitochondrial toxicity in rat liver |
| Q38193602 | Endoplasmic reticulum stress in drug- and environmental toxicant-induced liver toxicity |
| Q58549748 | Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy |
| Q36368683 | HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stages |
| Q28729025 | HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" study |
| Q41935715 | HIV/HAART-associated oxidative stress is detectable by metabonomics |
| Q38722124 | Harmonization of Mangiferin on methylmercury engendered mitochondrial dysfunction. |
| Q56829831 | High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study |
| Q58680687 | High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins |
| Q38383132 | High-content screening technology for studying drug-induced hepatotoxicity in cell models. |
| Q36868348 | Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. |
| Q38645161 | In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals. |
| Q90231170 | In vitro antioxidant efficacy and the therapeutic potential of Wendlandia heynei (Schult.) Santapau & Merchant against bisphenol A-induced hepatotoxicity in rats |
| Q46250998 | Increased MMAB level in mitochondria as a novel biomarker of hepatotoxicity induced by Efavirenz |
| Q30393445 | Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells |
| Q38695833 | Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds |
| Q36063046 | Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replication |
| Q38976612 | Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz |
| Q47757120 | Lon protease: a novel mitochondrial matrix protein in the interconnection between drug-induced mitochondrial dysfunction and endoplasmic reticulum stress. |
| Q35045143 | Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I. |
| Q38208324 | Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress |
| Q35223924 | Mitochondrial (dys)function - a factor underlying the variability of efavirenz-induced hepatotoxicity? |
| Q39295078 | Mitochondrial accumulation under oxidative stress is due to defects in autophagy. |
| Q36306214 | Mitochondrial alteration in malignantly transformed human small airway epithelial cells induced by α-particles |
| Q42700407 | Mitochondrial dysfunction induced by Bisphenol A is a factor of its hepatotoxicity in rats |
| Q93050517 | NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal |
| Q42090708 | PharmGKB summary: isoniazid pathway, pharmacokinetics. |
| Q28478275 | Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients |
| Q46257896 | Reactive oxygen species modulate itraconazole-induced apoptosis via mitochondrial disruption in Candida albicans |
| Q36663879 | Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy |
| Q36283681 | Robust glyoxalase activity of Hsp31, a ThiJ/DJ-1/PfpI family member protein, is critical for oxidative stress resistance in Saccharomyces cerevisiae |
| Q26765518 | Role of endoplasmic reticulum stress in drug-induced toxicity |
| Q37077573 | Role of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome. |
| Q47392916 | Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug-induced toxicity in vitro |
| Q35615469 | Suppression of Human T Cell Proliferation Mediated by the Cathepsin B Inhibitor, z-FA-FMK Is Due to Oxidative Stress |
| Q46271945 | The cathepsin B inhibitor z-FA-CMK induces cell death in leukemic T cells via oxidative stress |
| Q38955273 | The interplay between apoptosis, mitophagy and mitochondrial biogenesis induced by resveratrol can determine activated hepatic stellate cells death or survival |
| Q45732791 | Toxicological study and oxidative stress evaluation for safety assessment of xylanase preparations in Wistar rats |
| Q39034431 | Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies. |
| Q35206515 | bFGF attenuates endoplasmic reticulum stress and mitochondrial injury on myocardial ischaemia/reperfusion via activation of PI3K/Akt/ERK1/2 pathway |
Search more.